Sidewinder Therapeutics
Advancing precision bispecific antibody-drug conjugates to treat cancer
Understanding the changing shapes of cells as they grow is one key to understanding the biology of development and disease, but it’s hard to quantify morphology by eye. Deepcell’s benchtop microfluidics technology dissociates, sorts, and images single cells. Then the company’s machine learning software identifies distinguishing morphology, all without labeling or training. The resulting data opens the door for breakthroughs in cancer research, cell therapy, and developmental biology.
Advancing precision bispecific antibody-drug conjugates to treat cancer
Transforming the treatment of anxiety and other neuropsychiatric disorders
Putting protein-like drugs inside cells to fight cancer and neurodegeneration
Programming stem cells to differentiate into desired cell types, faster